Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2011 | 55 | 1 |
Tytuł artykułu

Antioxidative-related activities of lactoferrin and lactoperoxidase in milk from cows with different forms of mastitis

Warianty tytułu
Języki publikacji
Milk samples were taken from cows with acute, subacute, chronic, and subclinical mastitis and from healthy cows. The mean activity of lactoferrin (LF) in milk from mastitic cows ranged from 8.9 ±3.0 to 12.1 ±6.9 mU/g protein and was significantly lower than that in milk from healthy cows (29.5 ±15.0 mU/g protein). In group of mastitic cows the highest LF activity was found in cows with chronic mastitis, and the lowest in those with subclinical mastitis. The lactoperoxidase activity in cows with clinical and subclinical mastitis was significantly higher in comparison with healthy cows (1.3 ±1.1 mU/g protein) ranging from 5.5 ±2.6 mU/g protein in subclinical mastitic cows to 8.4 ±5.0 mU/g protein in chronic mastitic cows. Lower LF activities in cows with mastitis than in healthy animals may lead to a decreased antioxidant defence system in mastitic cows.
Opis fizyczny
  • Department and Clinic of Animal Reproduction, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, 20-612 Lublin, Poland
  • 1. Albera E., Kankofer M.: Antioxidants in colostrums and milk of sows and cows. Reprod Dom Anim 2009, 44, 606-611.
  • 2. Asadpour R., Tayefi-Nasrabadi H., Maghadam G., Nofouzi K.: Correlation between lactoperoxidase activity and somatic cell count for diagnosis subclinical mastitis in early lactation of dairy cows. J Anim Vet Adv 2008, 7, 777-779.
  • 3. Babior B.: Phagocytes and oxidative stress. Am J Med 2000, 109, 33-44.
  • 4. Barnes P.J., Karin M.: Nuclear factor-kB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336, 1066-1071.
  • 5. Batra T.R., Singh K., Ho S.K., Hidiroglou M.: Concentration of plasma and milk vitamin E and plasma ß-carotene of mastitic and healthy cows. Int J Vit Nutr Res 1992, 62, 233-237.
  • 6. Baveye S., Elass E., Mazurier J., Legrand D.: Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils. FEBS Lett 2000, 469, 5-8.
  • 7. Cochrane C.G.: Mechanism of oxidant injury of cells. Mol Aspects Med 1991, 12, 137-147.
  • 8. El-Chemaly S., Salathe M., Baier S., Conner G., Forteza R.: Hydrogen peroxide-scavenging properties of normal human airway secretions. Am J Resp Crit Care Med 167, 425-430.
  • 9. Farnaud S., Evans R.W.: Lactoferrin - a multifunctional protein with antimicrobial properties. Mol Immunol 2003, 40, 395-405.
  • 10. Hagiwara S., Kawai K., Anri A., Nagahata H.: Lactoferrin concentration in milk of bovine clinical mastitis. Vet Res Commun 1999, 23, 391-398.
  • 11. Hagiwara S., Kawai K., Hagiwara S., Anri A., Nagahata H.: Lactoferrin concentration in milk from normal and subclinical mastitic cows. J Vet Med Sci 2003, 65, 319- 323.
  • 12. Halliwell B.: Antioxidants in human health and disease. Ann Rev Nutr 1996, 16, 33-50.
  • 13. Halliwell B., Gutteridge J.M.: The importance of free radicals and catalytic metal ions in human disease. Mol Aspects Med 1985, 8, 89-133.
  • 14. Halliwell B., Gutteridge J.M.: The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990, 280, 1- 8.
  • 15. Halliwell B., Whiteman M.: Measuring reactive species and oxidative damage in vivo and in culture: how should you do it and what do the results mean? Br J Pharmacol 142, 231-255.
  • 16. Hillerton J., Berry E.: Treating mastitis in the cow - a tradition or an archaism. J Appl Microbiol 2005, 98, 1250-1255.
  • 17. Kawai K., Hagiwara S., Anri A., Nagahata H.: Lactoferrin concentration in milk of bovine clinical mastitis. Vet Res Commun 1999, 23, 391-398.
  • 18. Klyubin I.V., Kirpichnikova K.M., Gamaley I.A.: Hydrogen peroxide-induced chemotaxis of mouse peritoneal neutrophils. Eur J Cell Biol 1996, 70, 347-351.
  • 19. Komine K., Komine Y., Kuroishi T., Kobayashi J., Obara Y., Kumagai K.: Small molecule lactoferrin with an inflammatory effect but no apparent antibacterial activity in mastitic mammary gland secretion. J Vet Med Sci 2005, 67, 667-677.
  • 20. Kruidenier L., Verspaget H.: Oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Alim Pharmacol Therap 2002, 16, 1997-2026.
  • 21. Kussendrager K.D., van Hooijdonk A.C.: Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications. Br J Nutr 2000, 84. suppl.1, 19-25.
  • 22. Legrand D., Elass E., Carpentier M., Mazurier J.: Lactoferrin and host defence: an overview of its immuno- modulating and anti-inflammatory properties. Biometals 2004, 17, 225-229.
  • 23. Liu F., Ooi V., Chang S.: Free radical scavenging activities of mushroom polysaccharide extracts. Life Sci 1997, 60, 763-771.
  • 24. MacNee W.: Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001, 429, 195-207.
  • 25. Malinowski E., Kłossowska A.: Diagnostyka zakażeń i zapaleń wymienia. Ed. Natl Vet Res Institute, Pulawy, Poland, 2002.
  • 26. Mansson-Rahemtulla B., Baldone D., Pruitt K., Rahemtulla F.: Specific assays for peroxidases in human saliva. Arch Oral Biol 1986, 31, 661-668.
  • 27. Person M., Person C., Lester T., Rorie R. : Effects of milk antimicrobnial proteins on incidence of mastitis in dairy cattle. Arkansas Animal Sci Depart Rep 2007, pp.54-55.
  • 28. Pruitt K.M., Kamau D.N., Miller K., Mansson- Rahemtulla B., Rahemtulla F.: Quantitative, standardized assays for determining the concentrations of bovine lactoperoxidase, human salivary peroxidase and human myeloperoxidase. Anal Biochem 1990, 191, 278-286.
  • 29. Rao N.A., Romero J.L., Fernandez M.A., Sevanian A., Marak G.E.: Role of free radicals in uveitis. Surv Ophtalmol 1987, 32, 209-213.
  • 30. Rainard P.: Bacteriostatic activity of bovine milk lactoferrin against mastitic bacteria. Vet Microbiol 1986, 11, 387- 392.
  • 31. Reiter B., Haernulv G.: Lactoperoxidase antibacterial system. Natural occurrence, biological functions and practical applications. J Food Protect 1984, 47, 724-732.
  • 32. Schmedt Auf Der Gunne H., Tenhagen B., Kutzer P., Forderung D., Heuwieser W.: Laktoferrin, Lysozym und das Laktoperoxidase-Thiozyanat-Wasserstoffperoxid- System (LPS) als Ursache negativer mikrobiolischer Befunde aus Mastitissekreten? Dtsch Tierarztl Wochenschr 2002, 109, 300-305.
  • 33. Skrzydlewska E., Sulkowski S., Koda M., Zalewski B., Kanczuga-Koda L., Sulkowska M.: Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol 2005, 11, 403-406.
  • 34. Weiss S.I.: Tissue destruction by neutrophils. N Engl J Med 1989, 320, 365-376.
  • 35. Weiss W.P., Hogan J.S., Smith K.L.: Changes in vitamin C concentrations in plasma and milk from dairy cows after an intramammary infusion of Escherichia coli. J Dairy Sci 2004, 87, 32-37.
  • 36. Whitaker D., Macrea A., Burrough E.: Disposal and disease rates in British dairy herds between April 1998- and March 2002. Vet Rec 2004, 155, 43-47.
  • 37. Xiuyun Y., Yoshida S.: Lactoperoxidase and lactoferrin: changes in post partum milk during bovine lactational disorders. Milchwissenschaft 1995, 50, 67-71.
  • 38. Ye X., Wang H., Liu F., Ng T.: Ribonuclease, cell-free translation-inhibitory and superoxide radical scavenging activities of the iron-binding protein lactoferrin from bovine milk. Int J Biochem Cell Biol 2000, 32, 235-241.
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.